Compounds > pravastatin
Page last updated: 2024-08-23

pravastatin and Cerebral Arteriosclerosis

pravastatin has been researched along with Cerebral Arteriosclerosis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blauw, GJ; Bollen, EL; de Craen, AJ; Ford, I; ten Dam, VH; van Buchem, MA; van den Heuvel, DM; Westendorp, RG1
Belder, R; Nyyssönen, K; Park, JS; Porkkala, E; Rummukainen, J; Salonen, JT; Salonen, R1
Davis, BR; Meyers, DG; Rouleau, JL; Sacks, FM; Wilt, TJ1
Baldassarre, D; Bong, MG; Collatina, S; Crepaldi, G; Fisicaro, M; Gallus, G; Gobbi, C; Mancini, M; Ricci, G; Rimondi, S; Sirtori, CR; Veglia, F; Ventura, A1

Trials

4 trial(s) available for pravastatin and Cerebral Arteriosclerosis

ArticleYear
Effect of pravastatin on cerebral infarcts and white matter lesions.
    Neurology, 2005, May-24, Volume: 64, Issue:10

    Topics: Aged; Aged, 80 and over; Brain Ischemia; Cerebral Infarction; Cholesterol, LDL; Disease Progression; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Arteriosclerosis; Magnetic Resonance Imaging; Male; Nerve Fibers, Myelinated; Pravastatin; Prospective Studies; Telencephalon; Treatment Failure

2005
Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.
    Circulation, 1995, Oct-01, Volume: 92, Issue:7

    Topics: Anticholesteremic Agents; Arteriosclerosis; Carotid Artery Diseases; Carotid Artery, Common; Cholesterol, LDL; Cohort Studies; Double-Blind Method; Femoral Artery; Finland; Humans; Hypercholesterolemia; Intracranial Arteriosclerosis; Lipids; Male; Middle Aged; Pravastatin; Risk Factors; Smoking; Time Factors; Ultrasonography; Vitamin E

1995
Prevalence and correlates of symptomatic peripheral atherosclerosis in individuals with coronary heart disease and cholesterol levels less than 240 mg/dL: baseline results from the Cholesterol and Recurrent Events (CARE) Study.
    Angiology, 1996, Volume: 47, Issue:6

    Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Coronary Disease; Cross-Sectional Studies; Female; Humans; Intracranial Arteriosclerosis; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Peripheral Vascular Diseases; Pravastatin; Prevalence; Recurrence; Risk Factors; Smoking

1996
Intima-media thickness after pravastatin stabilizes also in patients with moderate to no reduction in LDL-cholesterol levels: the carotid atherosclerosis Italian ultrasound study.
    Atherosclerosis, 2000, Volume: 151, Issue:2

    Topics: Anticholesteremic Agents; Carotid Artery Diseases; Cholesterol, LDL; Disease Progression; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Arteriosclerosis; Lipids; Male; Middle Aged; Pravastatin; Tunica Intima; Tunica Media; Ultrasonography

2000